4.8 Article

Vaccine Activation of the Nutrient Sensor GCN2 in Dendritic Cells Enhances Antigen Presentation

Journal

SCIENCE
Volume 343, Issue 6168, Pages 313-317

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1246829

Keywords

-

Funding

  1. U.S. National Institutes of Health [R37 DK057665, R37 AI048638, U19 AI090023, U19 AI057266, U54 AI057157, N01 AI50019, N01 AI50025]
  2. Bill & Melinda Gates Foundation
  3. Wellcome Trust [084812/Z/08/Z]
  4. NIH [U54 AI057160]
  5. Wellcome Trust [084812/Z/08/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

The yellow fever vaccine YF-17D is one of the most successful vaccines ever developed in humans. Despite its efficacy and widespread use in more than 600 million people, the mechanisms by which it stimulates protective immunity remain poorly understood. Recent studies using systems biology approaches in humans have revealed that YF-17D-induced early expression of general control nonderepressible 2 kinase (GCN2) in the blood strongly correlates with the magnitude of the later CD8(+) T cell response. We demonstrate a key role for virus-induced GCN2 activation in programming dendritic cells to initiate autophagy and enhanced antigen presentation to both CD4(+) and CD8(+) T cells. These results reveal an unappreciated link between virus-induced integrated stress response in dendritic cells and the adaptive immune response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available